Impact of Early Progression on Long Term Outcomes Among Myeloma Patients Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Induction Therapy

Ajay K. Nooka; Jonathan L. Kaufman; Charise Gleason; Nisha S. Joseph; Craig C. Hofmeister; Lawrence Boise; Leonard T. Heffner; Madhav V. Dhodapkar; Sagar Lonial

doi:10.1182/blood-2018-99-120314

Impact of Early Progression on Long Term Outcomes Among Myeloma Patients Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Induction Therapy

Identifier:nobleid.org/w1/20260515/A0CCCD89

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A0CCCD89.svg?ark=w1%2F20260515%2FA0CCCD89)](https://nobleid.org/work/w1/20260515/A0CCCD89)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Impact of Early Progression on Long Term Outcomes Among Myeloma Patients Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Induction Therapy

Identifier:nobleid.org/w1/20260515/A0CCCD89

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A0CCCD89.svg?ark=w1%2F20260515%2FA0CCCD89)](https://nobleid.org/work/w1/20260515/A0CCCD89)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work